Ontology highlight
ABSTRACT:
SUBMITTER: Juric D
PROVIDER: S-EPMC5705193 | biostudies-literature | 2015 Jun
REPOSITORIES: biostudies-literature
Juric Dejan D Dienstmann Rodrigo R Cervantes Andres A Hidalgo Manuel M Messersmith Wells W Blumenschein George R GR Tabernero Josep J Roda Desamparados D Calles Antonio A Jimeno Antonio A Wang Xiaodong X Bohórquez Sandra Sanabria SS Leddy Cecilia C Littman Catherine C Kapp Amy V AV Shames David S DS Penuel Elicia E Amler Lukas C LC Pirzkall Andrea A Baselga José J
Clinical cancer research : an official journal of the American Association for Cancer Research 20150601 11
<h4>Purpose</h4>The novel dual-action humanized IgG1 antibody MEHD7945A targeting HER3 and EGFR inhibits ligand-dependent HER dimer signaling. This phase I study evaluated the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of MEHD7945A.<h4>Experimental design</h4>Patients with locally advanced or metastatic epithelial tumors received escalating doses of MEHD7945A (1-30 mg/kg) every 2 weeks (q2w) until disease progression or intolerable toxicity. An expansion cohort was enroll ...[more]